Technology Development Board enters into an agreement with Panacea Biotech
To provide financial assistance of Rs 28.99 crores for the development and commercialisation of dengue tetravalent vaccine.
Panacea Biotec has signed an agreement with Technology Development Board (TDB), Govt of India for providing the financial assistance of Rs 28.99 crores for the development and commercialisation of dengue tetravalent vaccine (Live Attenuated, Recombinant, Lyophilized).”
TDB approves support for indigenous company for ramping up production of COVID-19 diagnostic kits
Real-time PCR based molecular diagnostic kit that screens and detects COVID 19 from samples of flu-like symptoms.